| Literature DB >> 30231442 |
Brett Wilson1, Tom Provencher2, Jacqueline Gough3, Stephanie Clark4, Ramil Abdrachitov5, Karolien de Roeck6, Sarah Jane Constantine7, David Knepper8, Andy Lawton9.
Abstract
Central monitoring, on-site monitoring, and off-site monitoring provide an integrated approach to clinical trial quality management. TransCelerate distinguishes central monitoring from other types of central data review activities and puts it in the context of an overall monitoring strategy. Any organization seeking to implement central monitoring will need people with the right skills, technology options that support a holistic review of study-related information, and adaptable processes. There are different approaches actively being used to implement central monitoring. This article provides a description of how companies are deploying central monitoring, as well as samples of the workflows that illustrate how some have implemented it. The desired outcomes include earlier, more predictive detection of quality issues. This paper describes the initial implementation steps designed to learn what organizational capabilities are necessary.Entities:
Keywords: TransCelerate BioPharma; capabilities; central monitoring; implementation; risk-based monitoring
Year: 2014 PMID: 30231442 DOI: 10.1177/2168479014546335
Source DB: PubMed Journal: Ther Innov Regul Sci ISSN: 2168-4790 Impact factor: 1.778